A Study of the Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT

Clinical trial NCT00232635 · COMPLETED

Trial details

NCT number: NCT00232635
Sponsor: Arrow Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Respiratory Syncytial Virus Infections

Start date: 2005-09-01
Primary completion: 2006-07-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.